88 related articles for article (PubMed ID: 9252658)
1. Antitumor activity of novel tricyclic pyrone analogs in murine leukemia cells in vitro.
Perchellet JP; Newell SW; Ladesich JB; Perchellet EM; Chen Y; Hua DH; Kraft SL; Basaraba RJ; Omura S; Tomoda H
Anticancer Res; 1997; 17(4A):2427-34. PubMed ID: 9252658
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic pyrone analogs: a new class of microtubule-disrupting anticancer drugs effective against murine leukemia cells in vitro.
Newell SW; Perchellet EM; Ladesich JB; Freeman JA; Chen Y; Liu L; Hua DH; Kraft SL; Basaraba RJ; Perchellet JP
Int J Oncol; 1998 Feb; 12(2):433-42. PubMed ID: 9458372
[TBL] [Abstract][Full Text] [Related]
5. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
6. 5-benzyloxy-2-thiocyanatomethyl-4-pyranone, a novel heterocyclic compound: synthesis, structure determination and effects on neoplastic cell growth.
Bransová J; Uher M; Novotný L; Brtko J
Anticancer Res; 1997; 17(2A):1175-8. PubMed ID: 9137467
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
[TBL] [Abstract][Full Text] [Related]
8. 2-pyrones possessing antimicrobial and cytotoxic activities.
Fairlamb IJ; Marrison LR; Dickinson JM; Lu FJ; Schmidt JP
Bioorg Med Chem; 2004 Aug; 12(15):4285-99. PubMed ID: 15246105
[TBL] [Abstract][Full Text] [Related]
9. Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).
Griffin RJ; Srinivasan S; Bowman K; Calvert AH; Curtin NJ; Newell DR; Pemberton LC; Golding BT
J Med Chem; 1998 Dec; 41(26):5247-56. PubMed ID: 9857092
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
11. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
12. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of tricyclic pyrone analogs, a new synthetic class of microtubule de-stabilizing agents, in the murine EMT-6 mammary tumor cell line in vitro.
Perchellet EM; Ladesich JB; Chen Y; Sin HS; Hua DH; Kraft SL; Perchellet JP
Anticancer Drugs; 1998 Jul; 9(6):565-76. PubMed ID: 9877246
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of novel pyranopyrones derived from engineered aromatic polyketides.
Ridley CP; Khosla C
ACS Chem Biol; 2007 Feb; 2(2):104-8. PubMed ID: 17256996
[TBL] [Abstract][Full Text] [Related]
15. Regulation of selected biological processes in neoplastic cell lines by halogen derivatives of 5-hydroxy-2-hydroxymethyl-4-pyranone.
Bransová J; Uher M; Brtko J
Anticancer Res; 1998; 18(6A):4423-8. PubMed ID: 9891504
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
17. Novel pyrone side tetracyclic psoralen derivatives: synthesis and photobiological evaluation.
Dalla Via L; Uriarte E; Quezada E; Dolmella A; Ferlin MG; Gia O
J Med Chem; 2003 Aug; 46(18):3800-10. PubMed ID: 12930143
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of Howiinol A(GHM-10) on the synthesis of biological macromolecules in L1210 cells].
He J; Xu C
Yao Xue Xue Bao; 1998 Dec; 33(12):886-90. PubMed ID: 12016851
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of L-canavanine against L1210 murine leukemia.
Green MH; Brooks TL; Mendelsohn J; Howell SB
Cancer Res; 1980 Mar; 40(3):535-7. PubMed ID: 7471074
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, basicity, structural characterization, and biochemical properties of two [(3-hydroxy-4-pyron-2-yl)methyl]amine derivatives showing antineoplastic features.
Amatori S; Ambrosi G; Fanelli M; Formica M; Fusi V; Giorgi L; Macedi E; Micheloni M; Paoli P; Pontellini R; Rossi P
J Org Chem; 2012 Mar; 77(5):2207-18. PubMed ID: 22296279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
